dihexa n hexanoyl tyr ile 6 aminohexanamide 1,6-Diaminohexane for synthesis 124-09-4 3,6-Diaminohexanoic acid | C6H14N2O2 |
Description
Overall, there was a strong trend toward fewer deaths when compared to placebo control
The cause is unclear and thought to be combined genetic and environmental factors
A small fraction of users (under 5 percent) report mild anxiety alongside sleep disruption in the first week of dosing
Recent studies have also shown that response to anti-TNFs may be genetically determined
